In our work, we identified a patient with biallelic “likely pathogenic” variant in USP53, in association with low-GGT cholestasis, which extends the reports of USP53 mutation contributing to intrahepatic cholestasis. This evidence concerns the gene USP53 and intrahepatic cholestasis.